What UK stock market listing rules change mean

The reforms address a number of recommendations made in the UK Listing Review and the Kalifa Review of UK FinTech

AC Immune SA (ACIU)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

4.8500

-0.1700

(-3.39%)

At close: 04:00PM EST

4.8900

+0.04

(+0.82%)

After hours:

05:29PM EST

Currency in USD

Earnings estimate	Current qtr. (Dec 2021)	Next qtr. (Mar 2022)	Current year (2021)	Next year (2022)
No. of analysts	3	0	2	3
Avg. Estimate	0.11	0	-0.49	0.07
Low estimate	-0.33	0	-1.09	-0.01
High estimate	0.89	0	0.11	0.22
Year ago EPS	-0.3	-0.25	-0.96	-0.49

Revenue estimate	Current qtr. (Dec 2021)	Next qtr. (Mar 2022)	Current year (2021)	Next year (2022)
No. of analysts	3	0	3	3
Avg. Estimate	30.52M	N/A	30.63M	67.84M
Low estimate	N/A	N/A	N/A	N/A
High estimate	88.51M	N/A	88.84M	109.26M
Year ago sales	1.05M	N/A	17.2M	30.63M
Sales growth (year/est)	2,800.30%	N/A	78.10%	121.50%

Earnings history	30/12/2020	30/03/2021	29/06/2021	29/09/2021
Est. EPS	-0.28	-0.25	-0.26	-0.3
Actual EPS	-0.3	-0.25	-0.28	-0.24
Difference	-0.02	0	-0.02	0.06
Surprise %	-7.10%	0.00%	-7.70%	20.00%

EPS trend	Current qtr. (Dec 2021)	Current year (2021)	Next year (2022)
Current estimate	0.11	-0.49	0.07
7 days ago	0.11	-0.48	0.07
30 days ago	0.12	-0.44	0.1
60 days ago	0.12	-0.42	0.09
90 days ago	0.11	-0.41	0.1

EPS revisions	Current qtr. (Dec 2021)	Next qtr. (Mar 2022)	Current year (2021)	Next year (2022)
Up last 7 days	N/A	N/A	1	N/A
Up last 30 days	N/A	N/A	1	2
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	N/A	N/A

Growth estimates	ACIU	Industry	Sector(s)	S&P 500
Current qtr.	136.70%	N/A	N/A	N/A
Next qtr.	N/A	N/A	N/A	N/A
Current year	49.00%	N/A	N/A	N/A
Next year	114.30%	N/A	N/A	N/A
Next 5 years (per annum)	N/A	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A